Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy

Diabetologia
J LinH P Hammes

Abstract

Hyperglycaemia-induced mitochondrial overproduction of reactive oxygen species (ROS) is central to the pathogenesis of endothelial damage in diabetes. R-(+)-alpha-lipoic acid has advantages over classic antioxidants, as it distributes to the mitochondria, is regenerated by glycolytic flux, and has a low redox potential. To assess the effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy, three groups of male Wistar rats were studied: non-diabetic controls, untreated diabetic controls, and diabetic rats treated with 60 mg/kg bodyweight R-(+)-alpha-lipoic acid i.p. for 30 weeks. Quantitative retinal morphometry included acellular occluded capillaries and pericyte numbers. The effects of R-(+)-alpha-lipoic acid on parameters of oxidative and nitrative stress, AGE and its receptor and nuclear factor kappa B (NFkappaB) were assessed by immunoblotting, and NFkappaB activation by electrophoretic mobility shift assay. Angiopoietin-2 and vascular endothelial growth factors were also determined by immunoblotting. After 30 weeks of diabetes, the number of acellular capillaries was significantly elevated in diabetic rats (57.1+/-10.6 acellular capillary segments [ac]/mm(2) of retinal area) compared with non-diabetic (19.8+...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Apr 16, 1996·Biochemical and Biophysical Research Communications·I MaitraL Packer
Jun 15, 1996·The Journal of Clinical Investigation·M MizutaniM Lorenzi
Apr 29, 1998·The Journal of Clinical Investigation·M LuA P Adamis
Jun 2, 1998·Free Radical Biology & Medicine·J BustamanteB H Rihn
Feb 11, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T M HagenA B Ames
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jiankang LiuBruce N Ames
Sep 28, 2002·Diabetes·Hans-Peter HammesUrban Deutsch
Jul 29, 2003·Diabetes·Roya Babaei-JadidiPaul J Thornalley
Dec 4, 2003·Free Radical Biology & Medicine·Yunpeng DuT S Kern

❮ Previous
Next ❯

Citations

Feb 2, 2013·Journal of Molecular Histology·Serap Cilaker MiciliBekir Uğur Ergur
Jul 26, 2008·Reviews in Endocrine & Metabolic Disorders·Sally A Madsen-Bouterse, Renu A Kowluru
Nov 3, 2011·Diabetes Technology & Therapeutics·Marcella NebbiosoNicola Pescosolido
Mar 26, 2011·Diabetes, Obesity & Metabolism·C MorgadoI Tavares
Jul 21, 2007·Experimental Diabetes Research·Renu A Kowluru, Pooi-See Chan
Jun 21, 2007·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Yuxi FengHans-Peter Hammes
Jan 12, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Giuseppe MangialardiPaolo Madeddu
Mar 8, 2013·Future Medicinal Chemistry·Megha BarotAshim K Mitra
Aug 5, 2014·Antioxidants & Redox Signaling·Giuseppe MangialardiPaolo Madeddu
Jul 9, 2008·Free Radical Research·Siv Johnsen-SorianoFrancisco Javier Romero
Nov 22, 2007·Expert Opinion on Therapeutic Targets·Raymond M SchiffelersGert Storm
Jun 25, 2013·Expert Opinion on Pharmacotherapy·Marcella NebbiosoNicola Pescosolido
May 11, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Heena TabassumSheikh Raisuddin
Mar 24, 2010·Mechanisms of Ageing and Development·Robert Pazdro, John R Burgess
Sep 3, 2009·Clinical & Experimental Ophthalmology·Gina Y TsaiJoanne A Matsubara
Feb 13, 2009·British Journal of Pharmacology·Csaba Szabo
May 2, 2008·Annals of the New York Academy of Sciences·Ivan K LukicAngelika Bierhaus
Jan 15, 2015·Acta Ophthalmologica·Doreen SchmidlLeopold Schmetterer
Apr 13, 2012·Clinical Science·Ramaroson AndriantsitohainaIsmail Laher
Aug 30, 2016·Healthcare·Mark F McCarty, James DiNicolantonio
Aug 4, 2011·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Christos HaritoglouUNKNOWN RETIPON Study Group
Aug 12, 2014·Diabetology & Metabolic Syndrome·Marilia Brito Gomes, Carlos Antonio Negrato
Jun 15, 2007·American Journal of Physiology. Endocrinology and Metabolism·Michaela ArtwohlSabina M Baumgartner-Parzer
Oct 16, 2019·Inflammopharmacology·Benjamin G SpencerJohn W Finnie
Jul 6, 2020·Clinical and Experimental Pharmacology & Physiology·Thekkuttuparambil A Ajith
Mar 8, 2017·Oxidative Medicine and Cellular Longevity·Cheng LiJian Sun
Nov 11, 2017·The Journal of Clinical Endocrinology and Metabolism·Eugene J BarrettCarolina M Casellini
Apr 8, 2020·Oxidative Medicine and Cellular Longevity·Ricardo Raúl Robles-RiveraAdolfo Daniel Rodríguez-Carrizalez
Sep 13, 2019·Journal of Diabetes Research·Olvera-Montaño CeciliaRodríguez-Carrizalez Adolfo Daniel
Mar 5, 2017·European Journal of Nutrition·Yashodhara SharmaShankar Madhav Natu
Mar 9, 2021·Frontiers in Endocrinology·Josy AugustineTim M Curtis
Oct 27, 2006·Current Opinion in Ophthalmology
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.